TXMD - セラピュ―ティクスMD (TherapeuticsMD Inc.)

TXMDのニュース

   TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020  2020/10/29 11:00:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to hold conference call to discuss Q3 financial and business results on Monday, November 9 at 8:30 am ET
   Reviewing TherapeuticsMD (NASDAQ:TXMD) & Intra-Cellular Therapies (NASDAQ:ITCI)  2020/10/23 04:14:56 US Banking News
TherapeuticsMD (NASDAQ:TXMD) and Intra-Cellular Therapies (NASDAQ:ITCI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Earnings & Valuation This table compares TherapeuticsMD and Intra-Cellular Therapies’ top-line revenue, earnings per share and […]
   Comparing TherapeuticsMD (NASDAQ:TXMD) & Intra-Cellular Therapies (NASDAQ:ITCI)  2020/10/23 02:14:48 Daily Political
Intra-Cellular Therapies (NASDAQ:ITCI) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Profitability This table compares Intra-Cellular Therapies and TherapeuticsMD’s net margins, return on equity and return on […]
   TherapeuticsMD Inc (NASDAQ:TXMD) Receives Average Recommendation of “Hold” from Brokerages  2020/10/23 00:26:55 US Banking News
TherapeuticsMD Inc (NASDAQ:TXMD) has earned an average recommendation of “Hold” from the nine brokerages that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating on the company. The average 1 year price objective […]
   TherapeuticsMD Provides Update on Third Quarter Progress  2020/09/25 13:02:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--3Q Update PR
   TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences  2020/09/10 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to participate in two virtual investor conferences in September
   TherapeuticsMD Announces Patent Updates for ANNOVERA®  2020/09/09 20:05:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD increases patent protection on ANNOVERA
   TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020  2020/07/29 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET on such date to discuss the Company’s financial results and provide a business update. Conference Call & Audio Webcast
   TherapeuticsMD and Nurx Expand Access to ANNOVERA®  2020/07/15 10:50:00 Business Wire
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--TXMD expands access to Annovera through arrangement with Nurx, the largest online practice for women's health
   TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  2020/06/01 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional period. Mr. D’Arecca joins TherapeuticsM
   TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences  2020/09/10 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to participate in two virtual investor conferences in September
   TherapeuticsMD Announces Patent Updates for ANNOVERA®  2020/09/09 20:05:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD increases patent protection on ANNOVERA
   TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020  2020/07/29 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET on such date to discuss the Company’s financial results and provide a business update. Conference Call & Audio Webcast
   TherapeuticsMD and Nurx Expand Access to ANNOVERA®  2020/07/15 10:50:00 Business Wire
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--TXMD expands access to Annovera through arrangement with Nurx, the largest online practice for women's health
   TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  2020/06/01 10:50:00 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional period. Mr. D’Arecca joins TherapeuticsM

calendar